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Abstract
Background: Success in prevention of mother-to-child transmission (PMTCT) raises the prospect of eliminating pediatric
HIV infection. To achieve global elimination, however, strategies are needed to strengthen PMTCT interventions. This
study aimed to determine PMTCT outcomes and identify challenges facing its successful implementation in a rural
setting in Kenya.
Methods: A retrospective cohort design was used. Routine demographic and clinical data for infants and mothers
enrolling for PMTCT care at a rural hospital in Kenya were analysed. Cox and logistic regression were used to determine
factors associated with retention and vertical transmission respectively.
Results: Between 2006 and 2012, 1338 infants were enrolled and followed up for PMTCT care with earlier age of
enrollment and improved retention observed over time. Mother to child transmission of HIV declined from 19.4 % in 2006
to 8.9 % in 2012 (non-parametric test for trend p = 0.024). From 2009 to 2012, enrolling for care after 6 months of age,
adjusted Odds Ratio [aOR]: 23.3 [95 % confidence interval (CI): 8.3–65.4], presence of malnutrition ([aOR]: 2.3
[95 % CI: 1.1–5.2]) and lack of maternal use of highly active antiretroviral therapy (HAART) (aOR: 6.5 [95 % CI:
1.4–29.4]) was associated with increased risk of HIV infection. Infant’s older age at enrollment, malnutrition and
maternal HAART status, were also associated with drop out from care. Infants who were not actively followed
up were more likely to drop out from care (adjusted Hazard Ratio: 6.6 [95 % CI: 2.9–14.6]).
Discussion: We report a temporal increase in the proportion of infants enrolling for PMTCT care before 3
months of age, improved retention in PMTCT and a significant reduction in the proportion of infants enrolled
who became HIV-infected, emphasizing the benefits of PMTCT.
Conclusion: A simple set of risk factors at enrollment can identify mother-infant pairs most at risk of infection
or drop out for targeted intervention.
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Background
Mother to child transmission (MTCT) remains one of
the HIV pandemic’s most important challenges. In the
absence of preventive interventions, the risk of acquisi-
tion of HIV in utero or at birth is 15 to 30 %, increasing
to 20 to 45 % with breastfeeding [1, 2]. Prevention of
MTCT (PMTCT) strategies can reduce HIV vertical trans-
mission to less than 1 % in developed countries [1, 3] but
despite positive strides, less success is being achieved in
middle- and low-income countries [4].
There has been a call for “elimination” of pediatric HIV
[5], defined as 90 % reduction of new infant infections and
a decrease of MTCT to <5 %. However, global coverage of
PMTCT services remains below what is required to meet
this goal [6]. In sub-Saharan Africa, PMTCT coverage is
highly variable, with only 5 countries attaining >80 % cover-
age [7, 8]. In addition, reports of PMTCT coverage usually
reflect enrollment and initiation of PMTCT interventions,
rather than the completion of a multifaceted PMTCTcascade.
A diverse range of maternal, cultural and economic
challenges hinder the success of PMTCT in developing
countries [9, 10]. A recent review of data from low and
middle-income regions estimated PMTCT programme
losses of 49 % amongst HIV-infected pregnant women
between registration at the antenatal clinic and delivery,
loss of about 34 % of HIV exposed infants by 3 months of
age and loss of 45 % after HIV testing [9]. Malnutrition of-
fers additional challenges: growth impairment is reported
in infants born to HIV-infected mothers, including HIV-
exposed but uninfected infants [11, 12]. Poor nutritional
status in HIV-infected pregnant women may additionally
impair immunity and weaken epithelial integrity, which are
associated with vertical transmission of HIV [13]. Further-
more, acute maternal HIV infection late in pregnancy or
during breastfeeding may go unnoticed and it is associated
with very high risk of MTCT [14]. Vertical infection is esti-
mated at 27 % during acute infection [15, 16] compared to
9 to 16 % in chronically infected breastfeeding women in
the absence of therapy [17, 18].
If elimination of MTCT is to be achieved, then strat-
egies need to address the whole cascade of interventions.
In this study we aimed to describe retention in PMTCT
care up to 18 months of age, risk factors for non-retention
and the rate of MTCT of HIV infection amongst HIV-
exposed infants at a rural hospital in Kenya.
Methods
Study site
The study was conducted at the Comprehensive Care
and Research Clinic (CCRC), Kilifi County Hospital
(KCH), prior to a national recommendation in 2012 for in-
tegration of PMTCT services with Mother to Child Health
(MCH) services. At the time of the study, HIV infected
mothers delivering at the maternity department, KCH or
peripheral clinics were referred to the CCRC for con-
tinued PMTCT care as per the Kenyan guidelines [19].
In summary, the guidelines recommended that all preg-
nant women should be tested for HIV during their first
antenatal clinic visit and that a repeat test should be of-
fered to initially HIV negative women during the third
trimester. Mothers would be placed on life-long highly ac-
tive antiretroviral therapy (HAART) if their CD4 count
was less than 350 cells/mm3 but if higher, on prophylactic
antiretroviral therapy azidothymidine (AZT) from 14 weeks
of pregnancy (or at first contact with antenatal services, if
later) and AZT prophylaxis continued through labour and
1 week after delivery. HIV exposed infants born to mothers
not on HAART were prescribed nevirapine prophylaxis at
birth to be continued until 1 week after complete cessation
of breastfeeding while those with mothers on HAART, ne-
virapine prophylaxis stopped at 6 weeks of life. Infants aged
less than 18 months were tested for HIV by PCR at 6 weeks
after birth or at the earliest opportunity, subsequently an
antibody test at 9 months (if previously PCR negative) and
18 months was performed. Infants with confirmed HIV in-
fection at any of these test points were immediately put on
HAART. All HIV-exposed infants were given prophylactic
cotrimoxazole during the first 18 months of life and those
testing HIV positive at any of the testing time points con-
tinued on life-long cotrimoxazole. HAART and cotrimoxa-
zole were supplied at monthly visits.
Study population
We examined data from mother-infant pairs enrolling for
PMTCT care between 2009 and 2012. To assess PMTCT
completion we included infants who were under 18 months
old on 1st January 2009, but over 18 months on 31st
December 2013, which ensured that infants had suffi-
cient time to complete the 18 months follow up. In 2011,
a sub-set of infants were recruited into a study assessing
immune responses in HIV-exposed infants (outcomes
reported elsewhere). Infants recruited in the immune re-
sponse study received similar PMTCT care to other in-
fants at the clinic, but had study-related 3-monthly
follow-up visits, scheduled to coincide with one of the
infant’s routine PMTCT monthly visits. Defaulters in
the immune response study initially received two tele-
phone calls then a trained fieldworker was dispatched to
encourage the caregiver in bringing in the infant for care.
Transport costs for study related visits were reimbursed.
To examine numbers enrolled and changes in the pro-
portion of exposed infants who became HIV-infected over
time, we added data from our previous report on early in-
fant diagnosis of HIV infection from 2006 to 2008 [20].
Study design
In a retrospective cohort design, routinely collected data
from all eligible infants were considered in the analyses.
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Where possible, infant data were linked to maternal data
at delivery.
Sources of data and outcome definitions
Infants’ demographic and clinical data including gender,
residence and distance in kilometers to the hospital, date
of birth, date of enrollment into care, anthropometry, and
HAART use and prophylaxis were systematically captured
at each visit. Similarly, mothers’ demographic and clinical
data including age, education status, marital status, body
mass index (BMI), with a BMI of <18.5 considered as
malnutrition, CD4 T-cell count and HAART use were rou-
tinely captured.
In infants, malnutrition was defined as wasting (weight-
for-height z-score [WHZ< −2.0]), stunting (height-for-age
Z score [HAZ < −2.0]) and underweight (weight-for-age Z
score [WAZ < −2.0]) [21].
Retention in PMTCT was defined as infants remaining
in follow-up up to the recommended 18 months of age.
MTCT of HIV-1 was defined as infants who either tested
positive by polymerase chain reaction (PCR) at 6 weeks
(or at first contact) or by antibody tests at 9 or 18 months.
Sample size estimation
A post hoc sample size estimation was done as analyses
in this study were performed on routinely collected data.
We previously reported retention of 35 % among HIV-
exposed infants enrolled for care and followed up to
18 months of age [20]. Assuming similar retention rates,
the likelihood of 600 HIV-exposed infants being in follow-
up to 18 months of age would be estimated with a preci-
sion of +/−4 % at 95 % confidence levels. This number
also allows the risk of MTCT of HIV infection to be de-
scribed with a precision of about +/−2 %, assuming an es-
timated MTCT incidence of 6.5 % [22] and the prevalence
of malnutrition with a precision of about +/−3 % assuming
an estimated prevalence of 15 % [23].
Data analysis
Continuous data were presented using medians and inter-
quartile ranges (IQR) and categorical data using frequencies
and percentages. Variables with more than 10 % missing
data were considered, with missing recorded as a separate
category and included in the analyses as such. Logistic re-
gression models were used to describe independent corre-
lates of MTCT of HIV-1 infection. Odds ratios (OR), 95 %
confidence intervals (CI) and Likelihood Ratio Test (LRT)
p-values were presented. Cox proportional hazards regres-
sion models were used to assess independent predictors of
time to loss-to-follow up. Hazard Ratios (HR), 95 % CI and
LRT p-values were presented. We were unable to link a
quarter of the HIV-exposed infants to their mothers’
data. For this reason, regression models for each of the
outcomes as described above were applied separately and
independently for infants and mothers. All variables were
included in the multivariable models to adjust for any neg-
ative or positive residual confounding effects. All analyses
were carried out using STATA v12.0 (StataCorp, College
Station, Texas, USA).
Ethical considerations
Data analysed had been routinely collected at the clinic
and personal identifiers dropped. For the subset of mother-
infant pairs under active follow-up, written informed
Fig. 1 Enrollment for PMTCT care at a rural HIV clinic in Kenya. Infants enrolled between 2009 and 2012, and older than 18 months as at 31
December 2013 (n = 634), were matched to their mothers (n = 458) and used in the main analysis. Infants enrolled since 2006 were included in
the description of changes in enrollment and in HIV transmission over the years (n = 1338). PMTCT; Prevention of Mother to Child HIV-1 Transmission
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consent was obtained from the mother. Ethical permission
for this study was granted by the National Ethics and Re-
view Committee, Kenya Medical Research Institute with
reference number ERC 2085.
Results
Baseline characteristics at enrollment into care
Between 2006 and 2012, 1338 infants under 18 months
were enrolled for HIV care at the clinic. Of these 634
were enrolled between 2009 through 2012, were aged
18 months and above by December 2013 and included
in the main analysis (Fig. 1). From November 2011, 97
of the 634 infants were actively followed-up in a study
of immune responses. Overall, we were able to link 458/
634 [72 %] of the infants to their mothers’ data.
The number of infants enrolling at the clinic for PMTCT
systematically dropped over the years (Fig. 2), a trend sim-
ilar to enrollment for adult HIV care at the same clinic
(data not shown). The number of infants enrolling for
PMTCT within the first 3 months of life significantly
increased over the study period (non-parametric test for
trend, p < 0.001). Overall, 475 [74.9 %] infants enrolled be-
fore 3 months of age, and the median age of enrollment of
infants into care was 0.8 (IQR, 0.3 to 3.0) months (Table 1).
The majority of the infants were female (n = 366 [57.7 %]),
and 40 % (n = 246) lived within 5 km of the hospital.
The median maternal age at delivery was 28 (IQR, 24
to 34) years. Most mothers had primary education or
less (n = 369 [80.6 %]) and were not malnourished at
the time of delivery (BMI >18.5, n = 373 [81.4 %]). Their
median CD4 count at delivery was 410 (IQR, 279 to 571).
The majority of mothers were not on long-term HAART
(n = 279 [60.9 %]), with only a small proportion [19.8 %]
on continuous HAART for more than 2 years prior to
delivery.
Ninety-seven infants were enrolled into the immune re-
sponse study. Their baseline characteristics at enrollment
did not differ from those of infants under standard care
(Table 1).
Malnutrition at enrollment into care
Of the 634 exposed infants enrolled for HIV care during
the study period, 560 (88.3 %) had baseline weight, age
and height data available. A total of 285 infants (53.1 %)
exhibited at least one of the malnutrition syndromes (wast-
ing, underweight or stunting) and 26 (4.8 %) had a combin-
ation of all syndromes. The overall prevalence of wasting,
underweight and stunting was 14.0, 24.1 and 41.5 %
respectively (Table 2) and worsened with older age at
enrollment (correlation coefficients [95 % CI]: −0.096
([95 % CI: −0.143 to −0.049], p < 0.001); −0.099 ([95 %
CI: −0.136 to −0.062], p < 0.001) and −0.060 ([95 %
CI: −0.105 to −0.016], p = 0.008), respectively. Neither
the infant’s gender, residential area nor were maternal
characteristics associated with the infant’s nutritional
status at enrollment.
Retention in care over the recommended PMTCT 18-month
period
Overall, 634 infants were followed up and contributed a
total of 6577 person months of observation (pmo). Of
these, 247 (39.0 % [95 % CI, 35.1 to 42.9]) were lost to
follow-up before 18 months of age: incident rate 3.76
(95 % CI, 3.3 to 4.2)/100 pmo. Sixty-one (9.6 %) of
the nfants were enrolled but did not return for any
follow-up care, and by 9 months of age, 158 (26.4 %)
had dropped out.
The infant’s age, calendar year at enrollment, nutritional
status and active follow-up, were independently associated
with non-retention in care. Infants enrolled at >6 months
Fig. 2 Temporal changes in infant enrollment for PMTCT care at a rural HIV clinic in Kenya. Dashed line: infants enrolled each year. Light grey, mid-grey
and dark-grey bars represent age at enrollment: enrolled before 3 months, between 3 to 6 months and after 6 months of age respectively. The total
number of infants enrolled (n= 1338). PMTCT; Prevention of Mother to Child HIV-1 Transmission
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of age were almost twice as likely to drop out (Table 3). In-
fants enrolled in later calendar years had better retention in
care (p = 0.003). Infants with malnutrition syndromes at en-
rollment were more likely to drop out compared to those
without malnutrition. Infants not on active follow-up were
more likely to drop out of care, compared to those re-
ceiving active follow-up (HR [95 % CI] 6.6 [2.9 to 14.6],
p < 0.001).
Infants born to mothers with malnutrition at the time of
the infant’s birth had a higher rate of drop out from care
compared to those born to mothers without malnutrition
(HR [95 % CI] 1.6 [1.1 to 2.5], p = 0.036). Mothers not on
HAART for more than 2 years prior to the infant’s delivery
were almost three-fold more likely to drop out of PMTCT
care compared to mothers on long-term HAART (Table 3).
Correlates of MTCT of HIV-1 infection amongst infants
enrolled for PMTCT care
The proportion of enrolled infants who became HIV-
infected declined from 19.4 % in 2006 to 8.9 % in 2012
Table 1 Characteristics of HIV-exposed infants and their HIV-1 infected mothers enrolled for care at a rural HIV clinic in Kenya (N = 634)
Standard Care Active follow up Overall Care
Infants Characteristics N = 537 [%] N = 97 [%] N = 634 [%]
Gender Male 224 [41.7] 44 [45.4] 268 [42.3]
Female 313 [58.3] 53 [54.6] 366 [57.7]
Age at intake (months) Median (IQR) 0.9 (0.3–3.5) 0.6 (0.3–1.5) 0.8 (0.3–3.0)
Age group at enrollment (months) 0–3 394 [73.4] 81 [83.5] 475 [74.9]
3–6 52 [9.7] 13 [13.4] 65 [10.3]
>6 91 [17.9] 3 [3.1] 94 [14.8]
Hospital distance (kilometers) Median (IQR) 7.4 (2.2–13.4) 7.8 (2.2–17.7) 7.4 (2.2–13.4)
Hospital distance categories (kilometers) 0–5 206 [38.4] 40 [41.2] 246 [38.8]
5–10 136 [25.3] 22 [22.7] 158 [24.9]
>10 152 [28.3] 34 [35.1] 186 [29.3]
Missing 43 [8.0] 1 [1.0] 44 [6.9]
Mothers Characteristics (at infant’s birth) N = 364 [%] N = 94 [%] N = 458 [%]
Age (years) Median (IQR) 28.1 (23.3–33.5) 28.9 (24.8–34.9) 28.4 (23.7–33.8)
Age group (years) <25 120 [33.0] 24 [25.5] 144 [31.4]
25–35 177 [48.6] 47 [50.0] 224 [48.9]
>35 67 [18.4] 23 [24.5] 90 [19.7]
Education status No education 133 [36.5] 30 [31.9] 163 [35.6]
Primary 165 [45.3] 41 [43.6] 206 [45.0]
>Secondary 39 [10.7] 11 [11.7] 50 [10.9]
Missing 27 [7.4] 12 [12.8] 39 [8.5]
BMI Median (IQR) 21.0 (19.2–23.4) 21.4 (19.1–23.2) 21.0 (19.2–23.3)
BMI categories <18.5 56 [15.4] 15 [16.0] 71 [15.5]
>18.5 296 [81.3] 77 [81.9] 373 [81.4]
Missing 12 [3.3] 2 [2.1] 14 [3.1]
CD4 count Median (IQR) 409 (264–549) 420 (300–640) 410 (279–571)
CD4 count categories <350 85 [23.4] 25 [26.6] 110 [24.0]
>350 121 [33.2] 40 [42.6] 161 (35.2)
Missing 158 [43.4] 29 [30.9] 187 (40.8)
Duration on HAART (months) Median (IQR) 20.6 (2.9–36.9) 28.1 (7.1–44.6) 24.9 (3.4–39.3)
Duration on HAART categories (months) Not on HAARTa 229 [62.9] 50 [53.2] 279 [60.9]
0–24 71 [19.5] 17 [18.1] 88 [19.2]
>24 64 [17.6] 27 [28.7] 91 [19.8]
Infants missing mothers data (n = 176 [28 %]); BMI: body mass index, HAART: Highly active antiretroviral therapy, IQR interquartile range
amothers not on HAART received prophylactic antiretroviral therapy azidothymidine (AZT) during, through and after delivery, as per the Kenyan guidelines at the
time of the study, ref [19] if they had attended antenatal clinic
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[non-parametric test for trend, p = 0.024] (Fig. 3). Of the
634 infants within the study period (2009 to 2013), HIV
test results were available for 444 (70.0 %) infants. Over-
all, 57 infants became infected before age 18 months,
suggesting an overall MTCT risk during follow up of
12.8 % (95 % CI, 10.4–16.9) [Table 4]. More than half of
the infants who enrolled into care after 6 months of age
became HIV infected before age 18 months.
Age at enrollment, nutritional status, residential dis-
tance from the hospital and mothers’ HAART status at
the time of delivery were independently associated with
MTCT of HIV infection (Table 4). Infants enrolled into
care after 6 months of age had much higher odds of
HIV-infection compared to those enrolled for care within
3 months of age (aOR [95 % CI]: 23.3 [8.3 to 65.4],
p < 0.001) while infants who exhibited any of the mal-
nutrition syndromes were twice as likely to have acquired
HIV-1 (aOR [95 % CI]: 2.3 [1.0 to 5.2], p = 0.038). Infants
residing more than 10 km from the hospital were twice as
likely to acquire HIV infection compared to those living
within 5 km of the hospital. Infants born to mothers who
were not on HAART at the time of the infant’s birth had
more than six-fold odds of HIV infection compared to
those born to mothers who had been on HAART for more
than 24 months prior to delivery (aOR [95 % CI] 6.5 [1.4
to 29.4], p = 0.004).
Table 2 Distribution of nutritional status amongst HIV-exposed infants at enrollment for PMTCT care at a rural HIV clinic in Kenya (N = 634)
aWasting,
n = 479 [%]
bUnderweight
n = 526 [%]
cStunting
n = 528 [%]
dAny
n = 537 [%]
eAll
n = 539 [%]
Infants Characteristics 67/479 [14.0]f 135/526 [24.1]f 219/528 [41.5]f 285/537 [53.1]f 26/539 [4.8]f
Gender Male 34/212 [16.0] 67/241 [27.8] 100/229 [43.7] 128/233 [54.9] 15/232 [6.5]
Female 33/267 [12.4] 68/319 [21.3] 119/299 [39.8] 157/304 [51.6] 11/307 [3.6]
Age group (months) 0–3 38/352 [10.8] 80/425 [18.8] 157/403 [39.0] 202/407 [49.6] 9/407 [2.2]
3–6 9/51 [17.7] 19/56 [33.9] 23/48 [47.9] 33/52 [63.5] 4/53 [7.6]
>6 20/76 [26.3] 36/79 [45.6] 39/77 [50.7] 50/78 [64.1] 13/79 [16.5]
Hospital distance (kilometers) 0–5 23/184 [12.5] 49/221 [22.2] 85/208 [40.9] 110/209 [52.6] 8/215 [3.7]
5–10 15/125 [12.0] 41/144 [28.5] 56/135 [41.5] 75/141 [53.2] 5/134 [3.7]
>10 23/146 [15.8] 39/168 [23.2] 69/161 [42.9] 86/161 [53.4] 10/164 [6.1]
Cohort Standard Care 58/395 [14.7] 127/465 [27.3] 185/436 [42.4] 243/445 [54.6] 23/443 [5.2]
Active follow up 9/84 [10.7] 8/95 [8.4] 34/92 [37.0] 42/92 [45.7] 3/96 [3.1]
Mothers’ Characteristics
Age at infant’s birth (years) <25 18/116 [15.5] 32/141 [22.7] 52/134 [38.8] 70/135 [51.9] 5/134 [3.7]
25–35 24/191 [12.6] 39/220 [17.7] 81/209 [38.8] 106/212 [50.0] 8/214 [3.7]
>35 6/74 [8.1] 12/87 [13.8] 32/82 [39.0] 40/85 [47.1] 1/82 [1.2]
Education status No education 15/129 [11.6] 34/159 [21.4] 64/148 [43.2] 81/150 [54.0] 6/149 [4.0]
Primary 24/176 [13.6] 38/202 [18.8] 69/194 [35.6] 95/197 [48.2] 6/196 [3.1]
>Secondary 6/44 [13.6] 6/50 [12.0] 17/49 [34.7] 23/50 [46.0] 1/48 [2.1]
BMI at infants birth <18.5 9/55 [16.4] 17/69 [24.6] 29/66 [43.9] 38/67 [56.7] 3/63 [4.8]
>18.5 37/315 [11.8] 63/366 [17.2] 133/346 [38.4] 173/353 [49.0] 11/354 [3.1]
CD4 count at infants birth <350 13/88 [14.8] 21/107 [19.6] 40/100 [40.0] 55/104 [52.9] 4/104 [3.9]
>350 15/136 [11.0] 23/158 [14.6] 55/154 [35.7] 68/153 [44.4] 4/152 [2.6]
missing 39/255 [15.3] 91/295 [30.9] 124/274 [45.3] 162/280 [57.9] 18/283 [6.4]
Duration on HAART (months) Not on HAARTg 34/238 [14.3] 56/273 [20.5] 101/255 [39.6] 135/262 [51.5] 11/265 [4.2]
0–24 6/70 [8.6] 11/86 [12.8] 28/80 [35.0] 34/81 [42.0] 2/81 [2.5]
>24 8/73 [11.0] 16/89 [18.0] 36/90 [40.0] 47/89 [52.8] 1/84 [1.2]
BMI body mass index; HAART Highly active antiretroviral therapy; % percentages; PMTCT Prevention of mother-to-child transmission
aWasting: weight for height Z scores < −2.0
bUnderweight: weight for age Z score < −2.0
cStunting: height for age Z score < −2.0
dAny: infant with any of the three malnutrition syndromes
eAll: infant with all three malnutrition syndromes
fDifferent denominators arising from exclusion of missing data and extreme outliers after derivation of the Z-scores as outlined in the WHO reference data sets ref [21]
gmothers not on HAART received prophylactic antiretroviral therapy azidothymidine (AZT) during, through and after delivery, as per the Kenyan guidelines at the
time of the study, ref [19] if they had attended antenatal clinic
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Discussion
We report a temporal increase in the proportion of infants
enrolling for PMTCT care before 3 months of age and a
significant reduction in the proportion of infants enrolled
who became HIV-infected, emphasizing the benefits of
PMTCT. More than half of the infants completed the
18 months follow-up period, increase from 37 % previously
reported at the clinic [20]. Of concern is the 25 % of infants
enrolled for care after 3 months of age and therefore less
likely to optimally benefit from the care programme. Late
presentation for PMTCT care has similarly been reported
in an urban setting in Kenya with pregnant mothers mak-
ing less than four antenatal visits [24]. Such mothers are
also more likely to drop out of care [25, 26].
Table 3 Predictors of retention in care amongst HIV-exposed infants enrolled for PMTCT (N = 634)
Non-retention Cox Univariable analysis Cox Multivariable analysis
Infants Characteristics d/y [rate/100 pmo]a Crude HR [95 % CI] LRT p-valueb Adjusted HR [95 % CI]b LRT p-valueb
Gender Male 105/28.5 [3.7] Reference Reference
Female 142/37.3 [3.8] 1.0 [0.8–1.3] 0.810 1.1 [0.8–1.4] 0.662
Age group at intake (months) 0–3 179/56.9 [3.1] Reference Reference
3–6 30/5.1 [5.8] 1.8 [1.2–2.7] 2.1 [1.2–3.4]
>6 38/3.8 [10.1] 2.6 [1.8–3.8] <0.001 1.8 [1.1–3.0] 0.005
Year of intake 2009 113/19.2 [5.9] Reference Reference
2010 69/20.2 [3.4] 0.6 [0.4–0.8] 0.5 [0.4–0.8]
2011 37/19.7 [1.9] 0.3 [0.2–0.5] 0.5 [0.3–0.8]
2012 28/6.7 [4.2] 0.7 [0.5–1.1] <0.001 0.7 [0.4–1.4] 0.003
Any malnutrition at enrollment
(WHZ/WAZ/HAZ <−2.0)
No 78/31.3 [2.5] Reference Reference
Yes 111/29.7 [3.7] 1.5 [1.1–2.0] 0.008 1.5 [1.1–2.0] 0.018
All malnutrition at enrollment
(WHZ & WAZ & HAZ < −2.0)
No 175/59.6 [2.9] Reference Reference
Yes 13/1.2[10.7] 3.4 [1.9–6.0] <0.001 2.5 [1.3–4.7] 0.014
Hospital distance (kilometers) 0–5 95/27.1 [3.5] Reference Reference
5–10 57/17.2 [3.3] 0.9 [0.7–1.3] 0.9[0.6–1.4]
>10 70/18.6 [3.8] 1.1 [0.8–1.4] 0.818 1.1[0.8–1.6] 0.624
Cohort Active follow up 7/14.7 [0.5] Reference Reference
Standard Care 240/51.1 [4.7] 9.2 [4.3–19.5] <0.001 6.6 [2.9–14.6] <0.001
Mothers Characteristics
Age at infants birth (years) <25 53/17.3 [3.1] Reference Reference
25–35 81/28.0 [2.9] 1.0 [0.7–1.3] 1.2 [0.8–1.8]
>35 24/11.4 [2.1] 0.7 [0.4–1.1] 0.247 0.9 [0.5–1.6] 0.379
Education status No education 52/20.6 [2.5] Reference Reference
Primary 73/25.4 [2.9] 1.2 [0.8–1.7] 1.2 [0.8–1.7]
>Secondary 17/6.4 [2.7] 1.1 [0.6–1.8] 0.712 1.0 [0.5–1.8] 0.677
BMI at infants birth <18.5 33/8.5 [3.9] 1.6 [1.1–2.4] 1.6 [1.1–2.5]
>18.5 114/47.4 [2.4] Reference 0.016 Reference 0.036
CD4 count at infants birth >350 54/21.6 [2.5] Reference Reference
<350 39/15.2 [2.6] 1.0 [0.7–1.6] 1.2 [0.7–1.8]
Missing 65/19.9 [3.3] 1.3 [0.9–1.9] 0.254 1.2 [0.8–1.8] 0.685
Duration on HAART (months) Not on HAARTc 112/31.1 [3.6] 2.7 [1.6–4.5] 2.7 [1.5–4.7]
0–24 28/12.2 [2.3] 1.7 [0.9–3.1] 1.9 [1.0–3.7]
>24 18/13.3 [1.4] Reference <0.001 Reference <0.001
HR hazard ratios; CI confidence intervals; LRT Likelihood Ratio Tests; WHZ weight for height, WAZ weight for age, HAZ height for age z score; BMI body mass index;
HAART highly active antiretroviral therapy; PMTCT prevention of mother-to-child transmission
ad represents the number of events; y represents person months; PMO: time to loss to follow up is presented as the rate per 100 person months observed [rate/100pmo]
bLikelihood of an infant enrolled for Prevention of mother to child transmission of HIV dropping out of care before 18 months of life
cmothers not on HAART received prophylactic antiretroviral therapy azidothymidine (AZT) during, through and after delivery, as per the Kenyan guidelines at the
time of the study, ref [19] if they had attended antenatal clinic
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Late enrollment may be an indicator of underlying multi-
faceted problems [27, 28] or the reflection of a mother only
bringing her infant to clinic once the infant is not “thri-
ving”, and they may not have abided to earlier PMTCT
requirements [29]. Such mothers would therefore require
additional support besides starting PMTCT care. We ob-
served a temporal reduction in overall PMTCT enrollment,
a pattern replicated in the number of adults enrolling for
HIV care at the clinic, over the same period of time. From
2006, the Kenya government started decentralizing HIV
care services from referral hospitals to peripheral clinics. It
is likely that access to peripheral care facilities explains the
temporal reduction in enrollment since only a minimal
reduction in the HIV incidence rate (0.58 % per annum
in 2009 to 0.52 % per annum in 2011) has been re-
ported in women (ages 15–49 years) [5].
Once enrolled, 39 % of infants did not complete PMTCT
care. We were not in a position to ascertain whether some
of those lost to follow up were “self-transfers” to other
satellite clinics or true losses from the health care system.
Considerable heterogeneity in loss-to-follow up has been
reported in sub-Saharan Africa [9, 30]. The recent integra-
tion of PMTCT with the MCH service in our setting may
help improve retention [31, 32]. Interestingly, a recent re-
port showed no improvement on postnatal service uptake
or retention of mothers in care upon integration, however
maternal HIV care, enrollment and the use of HAART im-
proved [26]. Integration of PMTCT will also lead to an
increased service demand and systems burden at the
MCH and this will call for deliberate efforts to ensure
that quality care for both PMTCT and MCH services are
maintained [33]. The incorporation of expert clients at the
facilities, to assist with HAART clinic tasks including meas-
urement of vital signs, anthropometry and counseling, may
ease the burden on the health system and improve PMTCT
retention [34].
Using the available data we considered potential risk
factors for non-retention and their impact on the likel-
ihood of HIV-1 transmission. Previously maternal HIV
infection has been associated with poorer WHO growth
standards in HIV-exposed uninfected infants followed to
5 years [35] and underweight infants at 1 year [36]. Our
observations concur with previous studies that reported
sick or malnourished infants to be at higher risk of drop
out from care [27, 37]. Higher mortality rates are reported
in malnourished children [38–40] and potentially, increased
disease and death in this group may partly explain the
higher drop out we observed in malnourished infants.
Interestingly, residential distance from the hospital was
not associated with retention in care, although other studies
have shown that transport costs increase attrition [41].
Choice of a PMTCT facility away from one’s residential
area may be a reflection of underlying stigma or health
provider trust, although we did not measure this.
Although active follow-up was not randomized, the evi-
dence from the subset of infants actively followed up sug-
gests that this is a valuable intervention to improve
PMTCT, as previously observed [42, 43]. Research partici-
pation may have improved the mother’s interaction with
healthcare providers, understanding and hence attitude to-
wards PMTCTcare. Active follow-up poses additional costs,
but benefits may outweigh these relative to other interven-
tions against HIV. However, loss-to-follow up has previ-
ously been reported at 20 % of HIV-exposed and 14 % of
Fig. 3 Prevalence of HIV vertical transmission among infants enrolled for PMTCT care at a rural HIV clinic in Kenya Dotted lines: prevalence during
previous study, solid lines: prevalence during current study. Non-parametric test for trend, p = 0.024, confidence interval (CI) indicated. Total number of
infants (n = 1338). PMTCT; Prevention of Mother to Child HIV-1 Transmission, MTCT; Mother to child Transmission of HIV
Nduati et al. BMC Public Health  (2015) 15:1008 Page 8 of 12
HIV infected infants in spite of an active outreach follow-up
and food distribution programme, suggesting that other
factors may play a role [37]. Additional interventions may
be necessary, such as addressing stigma, improving atti-
tudes towards care programmes for instance through
integrated family approaches to improve retention [44],
the use of community support groups [45–48] and im-
proving mothers’ economic power [49].
Independently, maternal well-being resulted in better re-
tention, contrary to some observations that maternal well-
Table 4 Correlates of mother to child transmission of HIV-1 infection amongst HIV-1 exposed infants enrolled for care (N = 634)
HIV transmission
[%]
Logistic Univariable analysis Logistic Multivariable
analysis
Infants Characteristics n = 57/444a [12.8] Crude OR
[95 % CI]
LRT p-valueb Adjusted OR
[95 % CI]
LRT p-valueb
Gender Male 21/195 [10.8] Reference Reference
Female 36/249 [14.5] 1.4 [0.8–2.5] 0.246 1.4 [0.6–2.9] 0.431
Age group (months) 0–3 28/367 [7.6] Reference Reference
3–6 10/42 [23.8] 3.8 [1.7–8.5] 3.9 [1.3–12.2]
>6 19/35 [54.3] 14.4 [6.7–31.0] <0.001 23.3 [8.3–65.4] <0.001
Year of intake 2009 23/145 [15.9] Reference Reference
2010 16/131 [12.2] 0.7[0.4–1.5] 1.3 [0.5–3.6]
2011 14/123 [11.4] 0.7[0.3–1.4] 2.0 [0.6–6.3]
2012 4/45 [8.9] 0.5 [0.2–1.6] 0.553 0.6 [0.1–3.5] 0.480
Any malnutrition at intake (WHZ/WAZ/HAZ < −2.0) No 14/201 [7.0] Reference Reference
Yes 35/215 [16.3] 2.6 [1.4–5.0] 0.003 2.3 [1.0–5.2] 0.038
All malnutrition at intake (WHZ & WAZ & HAZ < −2.0) No 44/397 [11.1] Reference Reference
Yes 8/16 [50.0] 8.0 [2.9–22.4] <0.001 2.6 [0.6–10.8] 0.203
Hospital distance categories (kilometers) 0–5 20/180 [11.1] Reference Reference
5–10 9/117 [7.7] 0.7 [0.3–1.5] 0.6 [0.2–1.8]
>10 24/130 [18.5] 1.8 [1.0–3.4] 0.032 2.2 [0.9–5.2] 0.043
Cohort Active follow up 7/96 [7.3] Reference Reference
Standard Care 50/348 [14.4] 2.1 [0.9–4.9] 0.052 0.6 [0.2–1.8] 0.329
Mothers Characteristics
Age at infants birth (years) <25 12/114 [10.5] Reference Reference
25–35 14/192 [7.3] 0.7 [0.3–1.5] 0.9 [0.4–2.1]
>35 8/74 [10.8] 1.0 [0.4–2.7] 0.518 1.7 [0.6–5.1] 0.435
Education status No education 11/133 [8.3] Reference Reference
Primary 16/175 [9.1] 1.1 [0.5–2.5] 1.1 [0.5–2.6]
>Secondary 2/41 [4.9] 0.6 [0.1–2.7] 0.641 0.6 [0.1–2.9] 0.710
BMI at infants birth <18.5 6/59 [10.2] 1.2 [0.5–2.9] 1.3 [0.4–3.6]
>18.5 28/315 [8.9] Reference 0.757 Reference 0.660
CD4 count at infants birth >350 9/144 [6.3] Reference Reference
<350 7/98 [7.1] 1.2 [0.4–3.2] 1.5 [0.5–4.6] 0.215
Missing 18/138 [13.0] 2.3 [1.0–5.2] 0.113 2.2 [0.9–5.4]
Duration on HAART (months) Not on HAARTc 28/220 [12.7] 3.9 [1.1–13.2] 6.5 [1.4–29.4]
0–24 3/77 [3.9] 1.1 [0.2–5.5] 1.8 [0.3–11.2]
>24 3/83 [3.6] Reference 0.006 Reference 0.004
% percentage; OR Odds ratio; CI confidence intervals; LRT Likelihood Ratio Tests, p-values presented; whz weight for height; waz weight for age; haz height for age
z scores; BMI body mass index; HAART highly active antiretroviral therapy
anumber of infants for whom HIV test results were available
bLikelihood of infants enrolled for prevention of mother to child transmission of HIV care being vertically infected
cmothers not on HAART received prophylactic antiretroviral therapy azidothymidine (AZT) during, through and after delivery, as per the Kenyan guidelines at the
time of the study ref [19] if they had attended antenatal clinic
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being was a risk factor for poor retention [25, 28]. Our
results agree with previous findings that mothers already
receiving HAART were less likely to drop out [30].
We further addressed the impact of the above factors on
HIV transmission. We did not include prevalence in 2013,
since integration of PMTCT into the MCH altered the
programme strategy. Considerable progress has been made
in reducing MTCT in the past 7 years. In 2009, the clinic
improved its data capture system, which may explain the
increased prevalence observed that year. Increased risk of
HIV transmission by mothers not on life-long HAART
prior to delivery supports the need to improve maternal
health for better PMTCT outcomes [7, 50]. Mothers initiat-
ing HAART prior to conception have recently been shown
to have a lower chance of perinatally infecting their infants,
compared to those initiating HAART during pregnancy, in
spite of both controlling viraemia [51]. Life-time HAART
for the mother may help reduce transmission, improve
retention in care and by extension tracking her infant
[44, 52, 53]. Late enrollment into care was associated
with increased transmission as previously reported [54],
such mothers may benefit from timely initiation of
HAART. Maternal CD4 count did not correlate with HIV-
1 transmission, stratification of CD4 counts with HAART
use may have been more informative, but the small sample
size hindered a subgroup analysis.
Conclusion
In conclusion, our results show reducing MTCT over
the years and emphasize the benefits of early enroll-
ment into care, adequate infant nutrition and mother’s
health for PMTCT success. Observations from our clinic
concur with previous reports that the use and retention of
mother-infant pairs in PMTCT services is still challenging
[27, 37, 44, 55, 56]. Further understanding of factors both
cultural and economic that contribute to defaulting
PMTCT and the implementation of effective interven-
tions to track and retain infants in PMTCT are needed.
In addition measures to reduce missed opportunities
from non-enrollment for PMTCT, such as establishing
community based PMTCT [57] and participation of
traditional birth attendants [58] should be considered.
Our results suggest that a simple set of predictors can
identify mother-infant pairs at risk of infection or drop-
out during enrollment in order to implement active
intervention to retain them in care.
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